• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»preventive diagnostics

20/20 BioLabs and IBM collaboration signals new direction in preventive diagnostics

By Soujanya Ravi on February 26, 2026   Medical Devices & Diagnostics  

20/20 BioLabs and IBM collaboration signals new direction in preventive diagnostics

20/20 BioLabs launches AI-powered OneTest for longevity risk modeling. Discover what this means for preventive diagnostics and regulation.

Why Scilex Holding Company sees strategic optionality in diagnostic platforms beyond traditional therapeutics

By Soujanya Ravi on January 30, 2026   Features & Analysis  

Why Scilex Holding Company sees strategic optionality in diagnostic platforms beyond traditional therapeutics

Explore what Scilex Holding Company’s $20M Quantum Scan investment means for preventive diagnostics and the execution risks ahead.

Can MRI body scans redefine preventive care? AMRA expands into Dutch market with Prescan

By Pallavi Madhiraju on January 11, 2026   Medical Devices & Diagnostics  

Can MRI body scans redefine preventive care? AMRA expands into Dutch market with Prescan

AMRA and Prescan launch a first-in-Netherlands MRI scan to assess fat and muscle composition. Learn how this could redefine early disease detection in Europe.

Recent Posts

  • Can Servier’s $2.65bn Edgewise deal reshape the muscular dystrophy drug race?
  • Can Convergent Therapeutics define the next prostate cancer standard after Lu-PSMA therapy?
  • Why T-CURX’s Pantherna acquisition could matter for the future of cell therapy manufacturing
  • Is Amgen’s bispecific lung cancer drug becoming a global standard after chemotherapy failure?
  • Fulgent Genetics’ oncology pivot gets sharper as FID-007 shows Phase 2 activity at ASCO 2026
  • Minghui and Qilu push MHB088C forward as prostate cancer ADC race tightens
  • Why Aphranel’s EU MDR approval could sharpen competition in CaHA dermal fillers
  • Oricell’s ASCO 2026 liver cancer data put GPC3 CAR-T back in the spotlight
  • Can Lilly turn Hanmi’s sonefpeglutide into the next long-acting GLP-2 rare disease bet?
  • Can enicepatide and petrelintide help Genentech build a differentiated obesity franchise?
  • Can Summit and Akeso turn ivonescimab into a global lung cancer challenger?
  • Why Tempus AI’s Lens upgrade matters for precision oncology drug development
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes